Cited by 168Hormonal and reproductive studiesMenopause: Health Impacts and TreatmentsHypothalamic control of reproductive hormones

Comparison of screening questionnaires for the diagnosis of hypogonadism

Morley, John E., Perry, H.M., Kevorkian, R.T., Patrick, P.·2006·Maturitas

Abstract

Three questionnaires, the St. Louis University Androgen Deficiency in Aging Male (ADAM), the Aging Male Survey (AMS) and the Massachusetts Male Aging Study (MMAS), have been developed as potential screening tools for hypogonadism in older males. We compared these questionnaires in 148 males aged 23-80 years using bioavailable testosterone as the "biochemical gold standard" for diagnosis of hypogonadism. The sensitivity for the ADAM was 97%, for the AMS 83% and the MMAS 60%. Specificity was 30% for the ADAM, 59% for the MMAS and 39% for AMS. Both bioavailable testosterone and the calculated free testosterone correlated significantly with a number of the individual questions. Total testosterone correlated poorly with most of the questions. In conclusion, the ADAM and AMS may be useful screening tools for hypogonadism across the adult lifespan, but both are relatively nonspecific.

Integrity signals

Registry

Crossref · 10.1016/j.maturitas.2005.07.004

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Morley, J. E., Perry, H. M., Kevorkian, R. T., & Patrick, P.
Affiliations
St. Louis VA Medical Center (US)
Corresponding author
Morley, John E.
Venue
Maturitas
Publisher
Elsevier BV
Published
2006-03
Volume
53
Issue
4
Pages
424-429
ISSN
0378-5122 (ISSN-L)
OpenAlex
W2010090922
Cited by
168
References
39
Citations by year
2026: 2 · 2025: 5 · 2024: 10 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 5 · 2016: 8 · 2015: 10 · 2014: 10 · 2013: 11 · 2012: 13
FWCI
6.22
Type
journal article
Language
en
Open access
closed
Locations
  • Maturitas (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
hypogonadism, screening questionnaire, Massachusetts Male Aging Study, bioavailable testosterone, free testosterone, total testosterone, sensitivity and specificity, older men, androgen deficiency
MeSH terms
Adult, Aged, Aged, 80 and over, Humans, Hypogonadism, Male, Middle Aged, Surveys and Questionnaires, Sensitivity and Specificity, Testosterone, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review